English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduOpeolu Adeoye, MD a professor of emergency medicine at Washington University School of Medicine in St. Louis, led a national clinical trial that found that two anti-coagulant medications are ineffective at improving post-treatment outcomes for stroke patients.
Tag: Blood Clot
Is 100% survival after stroke achievable?
With a focus on reducing racial and gender disparities in health outcomes for stroke patients and creating adaptable, functional medical devices that can go from the lab to the surgical suite, the students are getting hands-on experience that is turning into inventions and job offers.
Novel Use of Existing Drug Could Significantly Cut Heart Attack Risk
Heart attacks have been the leading cause of death in the U.S. for a century. While most treatments for cardiac events target breaking down blood clots, Georgia Tech researchers have found a way to prevent blood clots from even forming. Dramatically, their drug is shown to completely knock out the formation of blood clots without increasing the risks of bleeds in vivo.
Research team led by Case Western Reserve awarded $2.75M from Department of Defense to advance clot-stabilizing nanotechnology
The U.S. Department of Defense (DoD) has awarded a team of researchers led by Case Western Reserve University a four-year, $2.75 million grant to explore new technology to generate and stabilize a protein called fibrin that is essential to maintain protective blood clots in an injured body.
Researchers explore whether gut microbes cause some COVID-19 patients to have higher blood clot risk
A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis — the formation of blood clots – researchers report February 23rd in the journal Cell Metabolism.
Cleveland Clinic Study Finds Common Artificial Sweetener Linked to Higher Rates of Heart Attack and Stroke
New Cleveland Clinic research showed that erythritol, a popular artificial sweetener, is associated with an increased risk of heart attack and stroke. Findings were published today in Nature Medicine.
Children’s Hospital Los Angeles Is First to Use New Device to Remove Atrial Blood Clot
A team at Children’s Hospital Los Angeles recently became the first in the world to use a novel, basket-shaped retrieval device to successfully remove a large right atrial thrombus (blood clot).
Stroke, Clot Risk Halved in Heart Disease and Arrhythmia Patients Who Took Blood Thinners Apixaban Versus Rivaroxaban
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
Risk of blood clots remains for almost a year after COVID-19 infection, study suggests
COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.
Patient Education and Feedback to Nurses Help Improve Administration Of Clot-Busting Drugs
Johns Hopkins Medicine study suggests strategies may prevent dangerous post-surgery condition
SuPAR identifies patients at high risk of blood clot formation
Blood clots are thought to occur in as many as a third of patients hospitalized with COVID-19. In many cases these clots can be deadly, such as pulmonary embolisms—blood clots that travel to the lungs. In fact, in nearly one third of patients with COVID-19, these clots led to death.
First Report of Minimally Invasive Aortic Valve Replacement Using Real-Time CT Imaging in Elderly Man with Heart Failure and Blood Clot
Cardiologists from the Structural and Congenital Heart Center and Cardiac Surgeons at Hackensack Meridian Hackensack University Medical Center/Hackensack Meridian School of Medicine have reported what is believed to be the very first patient with heart failure and a blood clot to undergo a minimally invasive transcatheter aortic valve replacement using CT (computed tomography) fusion imaging, a technique that employs two different imaging modalities.
Smartphone app can vibrate a single drop of blood to determine how well it clots
Researchers at the University of Washington have developed a new blood-clotting test that uses only a single drop of blood and a smartphone vibration motor and camera.
Important signs of blood clots in the lungs missed in patients with dementia
Patients with dementia who had signs and risk factors of a pulmonary embolism, or a blood clot in the lungs, were much less likely to be tested for pulmonary embolism than patients without dementia who had the same signs and risk factors.
Canadian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients
The investigators discovered that in moderately ill patients full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin.
Study Supports Early Anticoagulant Treatment to Reduce Death in Moderately Ill COVID-19 Patients
Findings from an international multicenter trials showed that while a full dose of heparin didn’t statistically significantly lower incidence of the primary composite of death, mechanical ventilation or ICU admission compared with low-dose heparin, therapeutic heparin did reduce the odds of all-cause death by 78 percent.
New NIH Grant Supports Ongoing UTSW Investigation of Debilitating Complications of Blood Clots in Teens
DALLAS – June 23, 2021 – UT Southwestern will lead a multicenter investigation into why children and young adults experience decreased physical activity and shortness of breath after experiencing blood clots, thanks to a four-year $2.97 million grant from the National Institutes of Health (NIH).
Subset of COVID-19 Patients Have Increased Bleeding Risk
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
Story Tips from Johns Hopkins Experts on COVID-19
Vaccines take time to work. After getting a COVID-19 vaccine, it takes a while for the immune system to fully respond and provide protection from the virus. For the Moderna and Pfizer COVID-19 vaccines, it takes up to two weeks after the second shot to become appropriately protected.
Researchers Explore COVID-19’s Effect on Pregnancy
Article title: Pregnancy and COVID-19 Authors: Elizabeth A.N. Wastnedge, Rebecca M. Reynolds, Sara R. van Boeckel, Sarah J. Stock, Fiona Denison, Jacqueline A. Maybin, Hilary O.D. Critchley From the authors: “From the current evidence base, it is difficult to draw…
Blood clotting abnormalities reveal COVID-19 patients at risk for thrombotic events
When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.
Blood Thinners may Improve Survival among Hospitalized COVID-19 Patients
Research could change standard of care protocols to prevent clotting associated with coronavirus
Respiratory Experts Find Clues on Risk Factors for COVID-19 Susceptibility
Elevated levels of plasmin(ogen)—an enzyme that helps prevent blood clots—is a common risk factor for COVID-19 susceptibility, according to a new review article co-authored by Hong-Long “James” Ji, MD, PhD; Runzhen Zhao, MD; Sadis Matalon, PhD, ScD; Michael A. Matthay,…
The Ultimate Telemedicine: UNC Expert Helps Treat Astronaut’s Blood Clot During NASA Mission
Moll was the only non-NASA physician NASA consulted when it was discovered that an astronaut aboard the ISS had a deep vein thrombosis (DVT) – or blood clot – in the jugular vein of their neck.